Targeted alpha anticancer therapies: update and future prospects

Targeted alpha therapy (TAT) is an emerging option for local and systemic cancer treatment. Preclinical research and clinical trials show that alpha-emitting radionuclides can kill targeted cancer cells while sparing normal cells, thus reducing toxicity. (223)RaCl(2) (Xofigo(®)) is the first alpha e...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Barry J, Huang, Chen-Yu, Clarke, Raymond A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232037/
https://www.ncbi.nlm.nih.gov/pubmed/25422581
http://dx.doi.org/10.2147/BTT.S29947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232037/
https://www.ncbi.nlm.nih.gov/pubmed/25422581
http://dx.doi.org/10.2147/BTT.S29947

Ejemplares similares